Kelly CRISPR & Gene Editing Technology ETF (XDNA) Holdings → Missed NVDA? Buy this AI stock NOW (From Chaikin Analytics) (Ad) Free XDNA Stock Alerts $7.38 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartHeadlinesHoldingsOptions ChainRatingsShort InterestSocial MediaStock AnalysisChartHeadlinesHoldingsOptions ChainRatingsShort InterestSocial Media Top 26 XDNA HoldingsRankCompanyCurrent PriceWeightShares Held1NTLAIntellia Therapeutics$24.46-1.6%11.05%6,6332TMOThermo Fisher Scientific$593.03+2.6%10.70%4843BEAMBeam Therapeutics$21.26-5.7%9.57%7,7554CRSPCRISPR Therapeutics$51.17-4.4%8.64%3,8615CRBUCaribou Biosciences$3.54-3.0%6.78%25,2236VERVVerve Therapeutics$6.01-5.5%5.63%7,194 Get the Latest News and Ratings for XDNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kelly CRISPR & Gene Editing Technology ETF and its competitors with MarketBeat's FREE daily newsletter. 7SGMOSangamo Therapeutics$0.56+7.7%5.16%99,3528PRMEPrime Medicine$5.61-1.9%4.73%8,1079ABBVAbbVie$160.75+0.2%4.37%73710EDITEditas Medicine$5.32-4.3%4.13%12,11111ALLOAllogene Therapeutics$2.76-3.5%4.10%21,17512Novartis AG Registered SharesN/A3.42%83613PSTXPoseida Therapeutics$2.65-2.2%3.32%49,02714DTILPrecision BioSciences$10.64-2.7%2.96%133,66115TSVT2seventy bio$4.38-1.1%2.87%9,33916AAgilent Technologies$149.76+3.2%2.40%48417BMYBristol-Myers Squibb$44.94+0.4%2.10%86918ILMNIllumina$110.53-0.7%2.00%26419Sanofi SAN/A1.90%46220VRTXVertex Pharmaceuticals$422.78+0.9%1.53%11021REGNRegeneron Pharmaceuticals$973.80+0.6%1.29%4422QGENQiagen$43.61+0.1%0.69%37423BIIBBiogen$221.50-0.6%0.57%5524DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.05%17,43925First American Government Obligs XN/A0.01%15426First American Treasury Obligs XN/A0.01%154 Related Companies and Tools Related Companies: Global X Wind Energy ETF Portfolio Companies Roundhill Daily 2X Long Magnificent Seven ETF Portfolio Companies Global X Emerging Markets Internet & E-commerce ETF Portfolio Companies Procure Disaster Recovery Strategy ETF Portfolio Companies Global X Education ETF Portfolio Companies First Trust Nasdaq Lux Digital Health Solutions ETF Portfolio Companies ProShares Ultra Cloud Computing Portfolio Companies SPDR MSCI USA Climate Paris Aligned ETF Portfolio Companies Global X PropTech ETF Portfolio Companies VanEck Green Infrastructure ETF Portfolio Companies This page (NASDAQ:XDNA) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial Metals[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kelly CRISPR & Gene Editing Technology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
